Structure |
Chemical Name |
CAS |
MF |
 |
Roxithromycin Impurity E |
|
|
 |
SofosBuvir impurity 48 |
|
|
 |
SofosBuvir Impurity 54 |
1431932-81-8 |
C12H17ClNO4P |
 |
Timolol EP Impurity G |
75202-36-7 |
C6H9N3O3S |
 |
Tofacitinib Impurity 44 |
2374700-39-5 |
C13H19N5 |
 |
Trelagliptin Impurity 24 |
|
|
 |
dimethyl 3- isobutylpentanedioate |
145328-03-6 |
C11H20O4 |
![Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]-](/CAS/20180601/GIF/1408077-50-8.gif) |
Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]- |
1408077-50-8 |
C15H15ClO2 |
![2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one](/CAS/20180601/GIF/1984788-96-6.gif) |
2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one |
1984788-96-6 |
C12H15N5O4 |
 |
Ampicillin Impurity C |
|
|
 |
Ampicillin Impurity O |
|
|
![(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate](/CAS/20180601/GIF/104873-15-6.gif) |
(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate |
104873-15-6 |
C17H18N2O7 |
 |
Lesinurad Impurity |
|
|
![7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl-](/CAS/20180601/GIF/1829588-57-9.gif) |
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl- |
1829588-57-9 |
C17H19ClN4O2 |
 |
Cefminox sodium impurities Ⅲ |
|
|
 |
Canagliflozin Impurity 18 |
1951467-29-0 |
C24H25FO6S |
 |
Fosaprepitant Impurity 6 |
327623-34-7 |
C21H19F6NO3 |
 |
Ivabradine Impurity 16 HCl |
304464-98-0 |
C26H34N2O5 |
 |
Moxifloxacin EP Impurity A HCl |
|
|
 |
Paroxetine EP Impurity H HCl |
503834-41-1 |
C19H23ClFNO |
 |
Solifenacin Related Compound 13 |
1251905-45-9 |
C17H17NO2 |
![1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide](/CAS/20180601/GIF/2101651-50-5.gif) |
1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide |
2101651-50-5 |
C14H12FN5 |
 |
N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide |
152504-12-6 |
C22H31ClN10 |
 |
N-エチル-N-メチルカルバモイルクロリド |
42252-34-6 |
C4H8ClNO |
 |
Cisatracurium-20-methyl Dibenzenesulfonate |
1193104-85-6 |
C60H79N2O15S+ |
![(3S)-N-[(1R)-1-フェニルエチル]-1-アザビシクロ[2.2.2]オクタン-3-アミン二塩酸塩](/CAS/GIF/128311-06-8.gif) |
(3S)-N-[(1R)-1-フェニルエチル]-1-アザビシクロ[2.2.2]オクタン-3-アミン二塩酸塩 |
128311-06-8 |
C15H24Cl2N2 |
 |
GURKHSYORGJETM-MGDILKBHSA-N |
1992961-26-8 |
C33H39ClN4O6 |
 |
DVCUGHHGLKCBMT-QVDQXJPCSA-N |
1356353-76-8 |
C15H24N6O6 |
 |
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |
![2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide](/CAS/20180601/GIF/1276524-56-1.gif) |
2,3,5,6-tetradeuterio-4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
1276524-56-1 |
C17H10D4F3N3O3S |
 |
1,1-ジフェニル-1-プロパノール |
5180-33-6 |
C15H16O |
 |
(R)-De(trifluoromethyl) Fluoxetine Hydrochloride |
1212215-97-8 |
C16H20ClNO |
![(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one](/CAS/20180601/GIF/96847-52-8.gif) |
(1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one |
96847-52-8 |
C11H10O2 |
![12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate](/CAS/20180703/GIF/176515-52-9.gif) |
12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
176515-52-9 |
C32H38N4O4 |
 |
4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
|
C17H24ClN3O2 |
 |
Ceftazidime Impurity D |
|
|
 |
Ceftazidime Sulfoxide Impurity |
|
|
 |
Tofacitinib Impurity Y |
|
|
 |
5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
|
C7H10ClN3OS |
 |
Landiolol impurity K |
190601-22-0 |
C19H29N3O6 |
 |
Crisaborole Impurity |
906673-42-5 |
C14H10BNO3 |
 |
Olanzapine impurity N |
|
C17H20N4S |
 |
Cabozantinib impurity 25 |
|
|
 |
Vildagliptin Impurity 39 |
|
|
 |
Tazobactam Impurity D |
|
|
 |
Palonosetron Impurity 22 |
1217547-14-2 |
C19H24N2O2 |
 |
Pitavastatin Impurity 35 |
|
|
 |
Pralatrexate Impurity 15 |
|
|
 |
Pitavastatin Impurity 52 |
|
|
 |
Pitavastatin Impurity 60 |
1661064-71-6 |
C25H22FNO3 |
 |
Lenvatinib Impurity 43 |
|
|
 |
Voriconazole Impurity 10 |
|
|
 |
Prednicarbate Impurity D |
|
|
 |
Olprinone Impurity A |
141354-29-2 |
C12H10N4O |
 |
Trelagliptin Impurity 16 |
|
|
 |
Decitabine Impurity 7 |
|
|
 |
Fosaprepitant Impurity 6 |
|
|
 |
Dapoxetine Impurity 6 |
|
|
 |
Regorafenib Impurity 13 |
|
|
 |
Topiroxostat Impurity 4 |
|
|
 |
Bosutinib Impurity 8 |
|
|
 |
Ticagrelor Impurity 13 |
|
|
 |
Ticagrelor Impurity 66 |
|
|
 |
Canagliflozin Impurity 8 |
|
|
 |
Canagliflozin Impurity 16 |
|
|
 |
Oseltamivir Impurity 12 |
|
|
 |
Oseltamivir Impurity 32 |
|
|
 |
Riociguat IMpurtiy E |
|
|
 |
Meropenem impurity diastereomer 2 |
96035-15-3 |
C15H19N3O5S |
 |
Clindamycin Impurity A |
|
|
 |
Tigecycline Impurity F |
|
|
 |
Fasudil iMpurity A |
|
|
 |
Cefminox Impurity C |
|
|
 |
4,5-ジブロモピロカテコール |
2563-26-0 |
C6H4Br2O2 |
 |
クロピドグレル関連化合物A |
144457-28-3 |
C15H14ClNO2S |
 |
RAC-(CIS/TRANS) ドネペジルN-オキシド |
120013-84-5 |
C24H29NO4 |
 |
5-カルボキシ-2'-デオキシウリジン |
14599-46-3 |
C10H12N2O7 |
 |
2-Desisopropyl-2-phenyl Repaglinide |
107362-12-9 |
C30H34N2O4 |
 |
2-(3-CHLOROPHENYL)-2-CYANO-1-(3-PYRIDINYL)-1-ETHANONE |
114444-10-9 |
C14H9ClN2O |
 |
Brivaracetam Impurity 37 |
|
|
 |
Ticagrelor Impurity 133 |
|
|
![4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-benzamide](/CAS/20200611/GIF/1187188-59-5.gif) |
4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-benzamide |
1187188-59-5 |
C14H12BNO4 |
![2-Propenoic acid, 3-[4-(hydroxymethyl)phenyl]-](/CAS/20200611/GIF/219915-41-0.gif) |
2-Propenoic acid, 3-[4-(hydroxymethyl)phenyl]- |
219915-41-0 |
C10H10O3 |
![L-Alanine, 3-[(R)-(carboxymethyl)sulfinyl]-](/CAS/20200611/GIF/61475-35-2.gif) |
L-Alanine, 3-[(R)-(carboxymethyl)sulfinyl]- |
61475-35-2 |
C5H9NO5S |
 |
アゾベンゼン-2-オール |
2362-57-4 |
C12H10N2O |
 |
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo- |
2410658-30-7 |
C15H14FNO5 |
 |
Hexanoic acid, 3-(hydroxymethyl)- |
81381-87-5 |
C7H14O3 |
![1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)-](/CAS/20211123/GIF/936226-36-7.gif) |
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[(dimethylamino)carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
936226-36-7 |
C30H36N6O10S2 |
![D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-, (1S)-](/CAS/20210111/GIF/946525-39-9.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-(1-methylethoxy)phenyl]methyl]phenyl]-, (1S)- |
946525-39-9 |
C22H27ClO6 |
 |
Topiroxostat Impurity 42 |
|
|
 |
Crisaborole intermediate |
1187188-60-8 |
C14H13BO4 |
 |
Regorafenib Impurity MHY |
|
|
 |
Lumateperone Impurity 6 |
313368-82-0 |
C23H26FN3O |
 |
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid) |
|
|
 |
4-Pyrimidineethanol, 6-bromo-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1307315-04-3 |
C16H13BrF3N5O |
![Cycloocta[b]pyridine, 2-(4-ethyl-1,4-dioxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-](/CAS/20200611/GIF/2247538-61-8.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1,4-dioxido-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- |
2247538-61-8 |
C23H30FN3O2 |
 |
Vonoprazan Impurity B-3 |
|
|
![3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-](/CAS/20210111/GIF/2271228-51-2.gif) |
3-Azetidineacetamide, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-51-2 |
C16H19N7O3S |
 |
Budesonide Impurity 26 |
|
|
 |
Peramivir Impurity 48 |
|
|